nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—AKR1B1—parotid gland—salivary gland cancer	0.0204	0.0886	CbGeAlD
Sulindac—AKR1B1—saliva-secreting gland—salivary gland cancer	0.0196	0.0848	CbGeAlD
Sulindac—MAPK3—neck—salivary gland cancer	0.0182	0.0788	CbGeAlD
Sulindac—AKR1B1—connective tissue—salivary gland cancer	0.018	0.0779	CbGeAlD
Sulindac—AKR1B1—epithelium—salivary gland cancer	0.0171	0.074	CbGeAlD
Sulindac—MAPK3—parotid gland—salivary gland cancer	0.0148	0.0642	CbGeAlD
Sulindac—MAPK3—saliva-secreting gland—salivary gland cancer	0.0142	0.0615	CbGeAlD
Sulindac—AKR1B1—lymphoid tissue—salivary gland cancer	0.0131	0.057	CbGeAlD
Sulindac—MAPK3—connective tissue—salivary gland cancer	0.013	0.0565	CbGeAlD
Sulindac—MAPK3—epithelium—salivary gland cancer	0.0124	0.0536	CbGeAlD
Sulindac—PPARD—lymphoid tissue—salivary gland cancer	0.0103	0.0448	CbGeAlD
Sulindac—MAPK3—lymphoid tissue—salivary gland cancer	0.00953	0.0413	CbGeAlD
Sulindac—AKR1B1—lymph node—salivary gland cancer	0.00742	0.0322	CbGeAlD
Sulindac—PPARD—lymph node—salivary gland cancer	0.00583	0.0253	CbGeAlD
Sulindac—MAPK3—lymph node—salivary gland cancer	0.00538	0.0233	CbGeAlD
Sulindac—CYP1A1—parotid gland—salivary gland cancer	0.00458	0.0199	CbGeAlD
Sulindac—CYP1A1—epithelium—salivary gland cancer	0.00383	0.0166	CbGeAlD
Sulindac—PTGS1—connective tissue—salivary gland cancer	0.00354	0.0154	CbGeAlD
Sulindac—PTGS2—connective tissue—salivary gland cancer	0.00338	0.0147	CbGeAlD
Sulindac—PTGS1—epithelium—salivary gland cancer	0.00336	0.0146	CbGeAlD
Sulindac—PTGS2—epithelium—salivary gland cancer	0.00321	0.0139	CbGeAlD
Sulindac—ALB—lymph node—salivary gland cancer	0.00256	0.0111	CbGeAlD
Sulindac—PTGS2—lymphoid tissue—salivary gland cancer	0.00247	0.0107	CbGeAlD
Sulindac—CYP1A1—lymph node—salivary gland cancer	0.00166	0.00721	CbGeAlD
Sulindac—PTGS1—lymph node—salivary gland cancer	0.00146	0.00633	CbGeAlD
Sulindac—PTGS2—lymph node—salivary gland cancer	0.0014	0.00605	CbGeAlD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000279	0.000362	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000278	0.000362	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ISYNA1—salivary gland cancer	0.000277	0.00036	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—HRAS—salivary gland cancer	0.000274	0.000356	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000274	0.000356	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—PIK3CA—salivary gland cancer	0.000272	0.000354	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MC3R—salivary gland cancer	0.000271	0.000352	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000271	0.000352	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—PIK3CA—salivary gland cancer	0.000269	0.00035	CbGpPWpGaD
Sulindac—MAPK3—Disease—NUP62—salivary gland cancer	0.000268	0.000349	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.000268	0.000348	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—PIK3CA—salivary gland cancer	0.000267	0.000347	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.000266	0.000346	CbGpPWpGaD
Sulindac—MAPK3—Disease—VCAN—salivary gland cancer	0.000266	0.000346	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—HRAS—salivary gland cancer	0.000262	0.000341	CbGpPWpGaD
Sulindac—CYP1A1—PPARA activates gene expression—EP300—salivary gland cancer	0.000262	0.00034	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—MAML2—salivary gland cancer	0.000262	0.00034	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000261	0.000339	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000261	0.000339	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MAP2K2—salivary gland cancer	0.00026	0.000339	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—salivary gland cancer	0.000259	0.000337	CbGpPWpGaD
Sulindac—PTGS2—Disease—MAML3—salivary gland cancer	0.000258	0.000336	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—salivary gland cancer	0.000257	0.000334	CbGpPWpGaD
Sulindac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—salivary gland cancer	0.000256	0.000333	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MARCKS—salivary gland cancer	0.000254	0.000331	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CREBBP—salivary gland cancer	0.000254	0.00033	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—salivary gland cancer	0.000253	0.000329	CbGpPWpGaD
Sulindac—ALB—Metabolism—ISYNA1—salivary gland cancer	0.000252	0.000328	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—HRAS—salivary gland cancer	0.000252	0.000327	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000251	0.000326	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—PIK3CA—salivary gland cancer	0.000251	0.000326	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000251	0.000326	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—HRAS—salivary gland cancer	0.000251	0.000326	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—HRAS—salivary gland cancer	0.00025	0.000325	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—HRAS—salivary gland cancer	0.000249	0.000324	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000249	0.000323	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—HRAS—salivary gland cancer	0.000248	0.000322	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—HRAS—salivary gland cancer	0.000247	0.000321	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000246	0.00032	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—EP300—salivary gland cancer	0.000246	0.00032	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000245	0.000319	CbGpPWpGaD
Sulindac—MAPK3—Disease—MAML2—salivary gland cancer	0.000243	0.000316	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PHGDH—salivary gland cancer	0.000243	0.000316	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—PTEN—salivary gland cancer	0.000242	0.000315	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—NOTCH1—salivary gland cancer	0.000242	0.000315	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—SMC1A—salivary gland cancer	0.000242	0.000314	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—NOTCH1—salivary gland cancer	0.000242	0.000314	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000238	0.00031	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—PIK3CA—salivary gland cancer	0.000237	0.000309	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—DTX4—salivary gland cancer	0.000237	0.000308	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PYGB—salivary gland cancer	0.000236	0.000307	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000236	0.000307	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ST3GAL4—salivary gland cancer	0.000234	0.000304	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—ATM—salivary gland cancer	0.000233	0.000303	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—salivary gland cancer	0.000233	0.000303	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000232	0.000302	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—HRAS—salivary gland cancer	0.000232	0.000302	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000232	0.000302	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000231	0.0003	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—HRAS—salivary gland cancer	0.00023	0.000299	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.00023	0.000298	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000228	0.000297	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000228	0.000296	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—HRAS—salivary gland cancer	0.000227	0.000295	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MARCKS—salivary gland cancer	0.000226	0.000293	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGFR4—salivary gland cancer	0.000224	0.000291	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000222	0.000289	CbGpPWpGaD
Sulindac—PTGS2—Disease—ST3GAL4—salivary gland cancer	0.000222	0.000288	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FBXW7—salivary gland cancer	0.00022	0.000286	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—CREBBP—salivary gland cancer	0.000219	0.000285	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—CREBBP—salivary gland cancer	0.000219	0.000285	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000217	0.000281	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—CREBBP—salivary gland cancer	0.000215	0.000279	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.000215	0.000279	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AQP1—salivary gland cancer	0.000212	0.000276	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.00021	0.000273	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PYGB—salivary gland cancer	0.00021	0.000273	CbGpPWpGaD
Sulindac—MAPK3—Disease—JAG1—salivary gland cancer	0.000208	0.00027	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGFR4—salivary gland cancer	0.000207	0.000269	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000206	0.000268	CbGpPWpGaD
Sulindac—ALB—Metabolism—MARCKS—salivary gland cancer	0.000206	0.000267	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000206	0.000267	CbGpPWpGaD
Sulindac—MAPK3—Disease—FBXW7—salivary gland cancer	0.000203	0.000264	CbGpPWpGaD
Sulindac—PTGS2—Disease—DTX4—salivary gland cancer	0.000201	0.000262	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—HRAS—salivary gland cancer	0.0002	0.00026	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—salivary gland cancer	0.0002	0.000259	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000199	0.000259	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000199	0.000258	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF16—salivary gland cancer	0.000196	0.000255	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CREBBP—salivary gland cancer	0.000193	0.000251	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000193	0.000251	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PHGDH—salivary gland cancer	0.000193	0.000251	CbGpPWpGaD
Sulindac—ALB—Metabolism—PYGB—salivary gland cancer	0.000191	0.000249	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00019	0.000247	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CCND1—salivary gland cancer	0.000188	0.000244	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FOXO3—salivary gland cancer	0.000186	0.000241	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ST3GAL4—salivary gland cancer	0.000186	0.000241	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PTEN—salivary gland cancer	0.000181	0.000236	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—salivary gland cancer	0.000177	0.00023	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ISYNA1—salivary gland cancer	0.000177	0.00023	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—salivary gland cancer	0.000176	0.000229	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.000174	0.000226	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EP300—salivary gland cancer	0.000173	0.000225	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000172	0.000224	CbGpPWpGaD
Sulindac—MAPK3—Disease—FOXO3—salivary gland cancer	0.000172	0.000223	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PHGDH—salivary gland cancer	0.000171	0.000222	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—PIK3CA—salivary gland cancer	0.000171	0.000222	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CREBBP—salivary gland cancer	0.000171	0.000222	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAML2—salivary gland cancer	0.00017	0.000221	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AQP1—salivary gland cancer	0.000169	0.000219	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NUP62—salivary gland cancer	0.000168	0.000219	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CCND1—salivary gland cancer	0.000168	0.000218	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—VCAN—salivary gland cancer	0.000167	0.000217	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF16—salivary gland cancer	0.000166	0.000216	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000166	0.000216	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ST3GAL4—salivary gland cancer	0.000165	0.000214	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.000161	0.000209	CbGpPWpGaD
Sulindac—PTGS2—Disease—NUP62—salivary gland cancer	0.00016	0.000207	CbGpPWpGaD
Sulindac—PTGS2—Disease—VCAN—salivary gland cancer	0.000158	0.000206	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—HRAS—salivary gland cancer	0.000158	0.000206	CbGpPWpGaD
Sulindac—ALB—Metabolism—PHGDH—salivary gland cancer	0.000156	0.000203	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—EP300—salivary gland cancer	0.000154	0.000201	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MAP2K2—salivary gland cancer	0.000152	0.000197	CbGpPWpGaD
Sulindac—ALB—Metabolism—ST3GAL4—salivary gland cancer	0.00015	0.000195	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CCND1—salivary gland cancer	0.00015	0.000195	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AQP1—salivary gland cancer	0.00015	0.000194	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—EP300—salivary gland cancer	0.000149	0.000194	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000147	0.000191	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—EP300—salivary gland cancer	0.000146	0.00019	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—JAG1—salivary gland cancer	0.000145	0.000189	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGFR4—salivary gland cancer	0.000145	0.000188	CbGpPWpGaD
Sulindac—PTGS2—Disease—MAML2—salivary gland cancer	0.000145	0.000188	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MARCKS—salivary gland cancer	0.000144	0.000187	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—HRAS—salivary gland cancer	0.000143	0.000186	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FBXW7—salivary gland cancer	0.000142	0.000185	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00014	0.000182	CbGpPWpGaD
Sulindac—MAPK3—Disease—MAP2K2—salivary gland cancer	0.00014	0.000182	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—PTEN—salivary gland cancer	0.000138	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—EP300—salivary gland cancer	0.000138	0.00018	CbGpPWpGaD
Sulindac—ALB—Metabolism—AQP1—salivary gland cancer	0.000136	0.000177	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000136	0.000177	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PYGB—salivary gland cancer	0.000134	0.000174	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NUP62—salivary gland cancer	0.000134	0.000174	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—VCAN—salivary gland cancer	0.000133	0.000172	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EP300—salivary gland cancer	0.000132	0.000171	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PIK3CA—salivary gland cancer	0.000128	0.000166	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—salivary gland cancer	0.000124	0.000161	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NOTCH1—salivary gland cancer	0.000124	0.000161	CbGpPWpGaD
Sulindac—PTGS2—Disease—JAG1—salivary gland cancer	0.000123	0.00016	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGFR4—salivary gland cancer	0.000123	0.00016	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PTEN—salivary gland cancer	0.000122	0.000158	CbGpPWpGaD
Sulindac—PTGS2—Disease—FBXW7—salivary gland cancer	0.000121	0.000157	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FOXO3—salivary gland cancer	0.00012	0.000156	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NUP62—salivary gland cancer	0.000119	0.000154	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HRAS—salivary gland cancer	0.000118	0.000154	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—VCAN—salivary gland cancer	0.000118	0.000153	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000116	0.000151	CbGpPWpGaD
Sulindac—PPARD—Metabolism—EP300—salivary gland cancer	0.000116	0.000151	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOTCH1—salivary gland cancer	0.000115	0.000149	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CREBBP—salivary gland cancer	0.000113	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—CREBBP—salivary gland cancer	0.000112	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CDH1—salivary gland cancer	0.000112	0.000145	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PHGDH—salivary gland cancer	0.000109	0.000142	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—PIK3CA—salivary gland cancer	0.000108	0.000141	CbGpPWpGaD
Sulindac—ALB—Metabolism—NUP62—salivary gland cancer	0.000108	0.000141	CbGpPWpGaD
Sulindac—ALB—Metabolism—VCAN—salivary gland cancer	0.000107	0.000139	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	0.000105	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—salivary gland cancer	0.000105	0.000136	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000105	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Disease—CREBBP—salivary gland cancer	0.000104	0.000135	CbGpPWpGaD
Sulindac—ALB—Hemostasis—CREBBP—salivary gland cancer	0.000103	0.000134	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000103	0.000134	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—HRAS—salivary gland cancer	0.000102	0.000133	CbGpPWpGaD
Sulindac—PTGS2—Disease—FOXO3—salivary gland cancer	0.000102	0.000133	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.000101	0.000131	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—HRAS—salivary gland cancer	0.0001	0.00013	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	9.98e-05	0.00013	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—salivary gland cancer	9.88e-05	0.000128	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAP2K2—salivary gland cancer	9.81e-05	0.000127	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—PIK3CA—salivary gland cancer	9.75e-05	0.000127	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AQP1—salivary gland cancer	9.54e-05	0.000124	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	9.41e-05	0.000122	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—HRAS—salivary gland cancer	9.02e-05	0.000117	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	8.95e-05	0.000116	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PIK3CA—salivary gland cancer	8.6e-05	0.000112	CbGpPWpGaD
Sulindac—PTGS2—Disease—MAP2K2—salivary gland cancer	8.33e-05	0.000108	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	8.31e-05	0.000108	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PTEN—salivary gland cancer	8.05e-05	0.000105	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOTCH1—salivary gland cancer	8.04e-05	0.000104	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.92e-05	0.000103	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EP300—salivary gland cancer	7.67e-05	9.98e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NUP62—salivary gland cancer	7.56e-05	9.83e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—VCAN—salivary gland cancer	7.5e-05	9.75e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTEN—salivary gland cancer	7.43e-05	9.66e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.38e-05	9.6e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	7.37e-05	9.59e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CREBBP—salivary gland cancer	7.29e-05	9.47e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—EP300—salivary gland cancer	7.09e-05	9.21e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—EP300—salivary gland cancer	7.04e-05	9.15e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.03e-05	9.14e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOTCH1—salivary gland cancer	6.82e-05	8.87e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	6.72e-05	8.74e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	6.58e-05	8.56e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CREBBP—salivary gland cancer	6.53e-05	8.48e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	6.41e-05	8.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PIK3CA—salivary gland cancer	6.21e-05	8.08e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CREBBP—salivary gland cancer	6.19e-05	8.04e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.86e-05	7.62e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HRAS—salivary gland cancer	5.75e-05	7.47e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PIK3CA—salivary gland cancer	5.68e-05	7.38e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCND1—salivary gland cancer	5.39e-05	7.01e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HRAS—salivary gland cancer	5.25e-05	6.83e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PIK3CA—salivary gland cancer	5.24e-05	6.81e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PIK3CA—salivary gland cancer	5.21e-05	6.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTEN—salivary gland cancer	5.2e-05	6.76e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.2e-05	6.76e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CREBBP—salivary gland cancer	5.18e-05	6.73e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—salivary gland cancer	5.04e-05	6.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EP300—salivary gland cancer	4.96e-05	6.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—HRAS—salivary gland cancer	4.85e-05	6.3e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—HRAS—salivary gland cancer	4.82e-05	6.26e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.74e-05	6.16e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	4.7e-05	6.11e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTEN—salivary gland cancer	4.66e-05	6.06e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CREBBP—salivary gland cancer	4.6e-05	5.98e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	4.48e-05	5.83e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—EP300—salivary gland cancer	4.45e-05	5.78e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PTEN—salivary gland cancer	4.42e-05	5.74e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—EP300—salivary gland cancer	4.21e-05	5.48e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CREBBP—salivary gland cancer	4.19e-05	5.45e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PTEN—salivary gland cancer	3.7e-05	4.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3CA—salivary gland cancer	3.67e-05	4.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—salivary gland cancer	3.55e-05	4.62e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—EP300—salivary gland cancer	3.53e-05	4.59e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HRAS—salivary gland cancer	3.4e-05	4.41e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	3.32e-05	4.31e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3CA—salivary gland cancer	3.29e-05	4.27e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTEN—salivary gland cancer	3.28e-05	4.27e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—EP300—salivary gland cancer	3.13e-05	4.07e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PIK3CA—salivary gland cancer	3.12e-05	4.05e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTEN—salivary gland cancer	2.99e-05	3.89e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CREBBP—salivary gland cancer	2.93e-05	3.81e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—HRAS—salivary gland cancer	2.88e-05	3.75e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—EP300—salivary gland cancer	2.86e-05	3.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3CA—salivary gland cancer	2.61e-05	3.39e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3CA—salivary gland cancer	2.32e-05	3.01e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3CA—salivary gland cancer	2.11e-05	2.75e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTEN—salivary gland cancer	2.09e-05	2.72e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—EP300—salivary gland cancer	2e-05	2.6e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	1.48e-05	1.92e-05	CbGpPWpGaD
